Evidence map›Paper›PMID 39257804›Full record

ArticlebioRxiv : the preprint server for biology2024

Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity.

Tigist Y Tamir, Shreya Chaudhary, Annie X Li, Sonia E Trojan, Cameron T Flower, Paula Vo, Yufei Cui, Jeffrey C Davis, Rachit S Mukkamala, Francesca N Venditti and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Tigist Y TamirKoch Institute for Integrative Cancer Research.ORCID 0000-0002-8194-8754
Shreya ChaudharyKoch Institute for Integrative Cancer Research.
Annie X LiKoch Institute for Integrative Cancer Research.ORCID 0009-0000-7685-9389
Sonia E TrojanKoch Institute for Integrative Cancer Research.ORCID 0000-0001-8876-6294
Cameron T FlowerKoch Institute for Integrative Cancer Research.ORCID 0000-0002-9632-9913
Paula VoDana-Farber Cancer Institute, Boston, MA, USA.
Yufei CuiKoch Institute for Integrative Cancer Research.ORCID 0000-0003-3014-813X
Jeffrey C DavisKoch Institute for Integrative Cancer Research.ORCID 0000-0003-0418-9106
Rachit S MukkamalaKoch Institute for Integrative Cancer Research.ORCID 0009-0000-8318-2257
Francesca N VendittiKoch Institute for Integrative Cancer Research.ORCID 0009-0001-9487-4395
Alissandra L HillisDepartment of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-6667-1291
Alex TokerDepartment of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-0723-4419
Matthew G Vander HeidenKoch Institute for Integrative Cancer Research.ORCID 0000-0002-6702-4192
Jessica B SpinelliProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0003-3657-4578
Norman J KennedyProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Roger J DavisProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-0130-1652
Forest M WhiteKoch Institute for Integrative Cancer Research.ORCID 0000-0002-1545-1651

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
National Metabolomics Data Repository - nextgen Metabolomics WorkbenchU2CDK119886 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANIAM, SHANKAR · 2018 to 2021
$12.7M
Quantitative systems biology of glioblastoma cells and their interactions with the neuronal and immunological milieuU54CA283114 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Forest M White · 2023 to 2026
$9.7M
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in CancerR35CA253097 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Alex Toker · 2020 to 2026
$6.9M
Understanding the role of metabolism in cancerR35CA242379 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VANDER HEIDEN, MATTHEW G. · 2019 to 2025
$5.8M
Graduate Training in Computational and Systems BiologyT32GM087237 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BURGE, CHRISTOPHER B · 2009 to 2023
$4.6M
Adipose Tissue Metabolic Stress ResponsesR01DK112698 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DAVIS, ROGER J. · 2017 to 2025
$4.4M
Metabolic Stress SignalingR01DK107220 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DAVIS, ROGER J. · 2016 to 2023
$3.6M
Biomedical Data Commons Workbench (BDCW)OT2OD030544 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANIAM, SHANKAR · 2020 to 2024
$3.2M
Identification of adaptive response mechanisms in breast cancer by information theory and proteomicsU01CA238720 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KRAVCHENKO-BALASHA, NATALY, WHITE, FOREST M · 2019 to 2023
$2.0M
Regulation of oxidative stress signaling by tyrosine phosphorylation of antioxidant enzymesK99GM152834 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI TAMIR, TIGIST Y · 2023 to 2024
$175k
Metabolic Regulation of Pancreatic Epithelium DevelopmentF32HD108930 · NICHD · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI DAVIS, JEFFREY CARL · 2022 to 2024
$160k
NCI NIH HHS P30 CA014051NCI NIH HHS R35 CA242379NCI NIH HHS R35 CA253097NCI NIH HHS U01 CA238720NCI NIH HHS U54 CA283114NICHD NIH HHS F32 HD108930NIDDK NIH HHS R01 DK107220NIDDK NIH HHS R01 DK112698NIDDK NIH HHS U2C DK119886NIGMS NIH HHS K99 GM152834NIGMS NIH HHS T32 GM087237NIH HHS OT2 OD030544
6 · The paper itself

Abstract

Coordination of adaptive metabolism through cellular signaling networks and metabolic response is essential for balanced flow of energy and homeostasis. Post-translational modifications such as phosphorylation offer a rapid, efficient, and dynamic mechanism to regulate metabolic networks. Although numerous phosphorylation sites have been identified on metabolic enzymes, much remains unknown about their contribution to enzyme function and systemic metabolism. In this study, we stratify phosphorylation sites on metabolic enzymes based on their location with respect to functional and dimerization domains. Our analysis reveals that the majority of published phosphosites are on oxidoreductases, with particular enrichment of phosphotyrosine (pY) sites in proximity to binding domains for substrates, cofactors, active sites, or dimer interfaces. We identify phosphosites altered in obesity using a high fat diet (HFD) induced obesity model coupled to multiomics, and interrogate the functional impact of pY on hepatic metabolism. HFD induced dysregulation of redox homeostasis and reductive metabolism at the phosphoproteome and metabolome level in a sex-specific manner, which was reversed by supplementing with the antioxidant butylated hydroxyanisole (BHA). Partial least squares regression (PLSR) analysis identified pY sites that predict HFD or BHA induced changes of redox metabolites. We characterize predictive pY sites on glutathione S-transferase pi 1 (GSTP1), isocitrate dehydrogenase 1 (IDH1), and uridine monophosphate synthase (UMPS) using CRISPRi-rescue and stable isotope tracing. Our analysis revealed that sites on GSTP1 and UMPS inhibit enzyme activity while the pY site on IDH1 induces activity to promote reductive carboxylation. Overall, our approach provides insight into the convergence points where cellular signaling fine-tunes metabolism.

Indexed as

computational modelingGSTP1IDH1metabolismmetabolomicsoxidative stress responsephosphoproteomicsreductive metabolismUMPS

Identifiers

PMID39257804
PMCPMC11383994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.